These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10963790)

  • 1. alpha(2)-plasmin inhibitor is a substrate for tissue transglutaminase: an in vitro study.
    Hevessy Z; Patthy A; Kárpáti L; Muszbek L
    Thromb Res; 2000 Aug; 99(4):399-406. PubMed ID: 10963790
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of amino acids in antiplasmin involved in its noncovalent 'lysine-binding-site'-dependent interaction with plasmin.
    Wang H; Yu A; Wiman B; Pap S
    Eur J Biochem; 2003 May; 270(9):2023-9. PubMed ID: 12709062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-linking of wild-type and mutant alpha 2-antiplasmins to fibrin by activated factor XIII and by a tissue transglutaminase.
    Lee KN; Lee CS; Tae WC; Jackson KW; Christiansen VJ; McKee PA
    J Biol Chem; 2000 Dec; 275(48):37382-9. PubMed ID: 10958788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor XIII-mediated cross-linking of NH2-terminal peptide of alpha 2-plasmin inhibitor to fibrin.
    Ichinose A; Tamaki T; Aoki N
    FEBS Lett; 1983 Mar; 153(2):369-71. PubMed ID: 6617867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antifibrinolytic function of factor XIII is exclusively expressed through α₂-antiplasmin cross-linking.
    Fraser SR; Booth NA; Mutch NJ
    Blood; 2011 Jun; 117(23):6371-4. PubMed ID: 21471521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosslinking of alpha 2-antiplasmin to fibrin.
    Lee KN; Lee CS; Tae WC; Jackson KW; Christiansen VJ; McKee PA
    Ann N Y Acad Sci; 2001; 936():335-9. PubMed ID: 11460490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The binding sites on fibrin(ogen) for guinea pig liver transglutaminase are similar to those of blood coagulation factor XIII. Characterization of the binding of liver transglutaminase to fibrin.
    Achyuthan KE; Mary A; Greenberg CS
    J Biol Chem; 1988 Oct; 263(28):14296-301. PubMed ID: 2902081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplasmin: the forgotten serpin?
    Coughlin PB
    FEBS J; 2005 Oct; 272(19):4852-7. PubMed ID: 16176259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-linking of plasminogen activator inhibitor 2 and alpha 2-antiplasmin to fibrin(ogen).
    Ritchie H; Lawrie LC; Crombie PW; Mosesson MW; Booth NA
    J Biol Chem; 2000 Aug; 275(32):24915-20. PubMed ID: 10816585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of alpha 2-plasmin inhibitor].
    Mimuro J; Aoki N
    Rinsho Byori; 1985 Feb; Spec No 61():97-105. PubMed ID: 2860263
    [No Abstract]   [Full Text] [Related]  

  • 11. The plasmin-antiplasmin system: structural and functional aspects.
    Schaller J; Gerber SS
    Cell Mol Life Sci; 2011 Mar; 68(5):785-801. PubMed ID: 21136135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular form of alpha 2-antiplasmin with affinity for plasminogen is selectively bound to fibrin by factor XIII.
    Kluft C; Los P; Jie AF
    Thromb Res; 1984 Feb; 33(4):419-25. PubMed ID: 6710441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin-antithrombin complex and alpha2-plasmin inhibitor-plasmin complex levels after cesarean section in normal pregnancies and pre-eclampsia.
    Hayashi M; Hamada Y; Ohkura T
    Int J Gynaecol Obstet; 2003 Aug; 82(2):213-6. PubMed ID: 12873784
    [No Abstract]   [Full Text] [Related]  

  • 14. Determinants of substrate specificity for factor XIII.
    McDonagh J; Fukue H
    Semin Thromb Hemost; 1996; 22(5):369-76. PubMed ID: 8989819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor.
    Sakata Y; Aoki N
    J Clin Invest; 1980 Feb; 65(2):290-7. PubMed ID: 6444305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-linking of alpha 2-plasmin inhibitor to fibrin catalyzed by activated fibrin-stabilizing factor.
    Tamaki T; Aoki N
    J Biol Chem; 1982 Dec; 257(24):14767-72. PubMed ID: 6129243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elastase inhibitor elafin is a new type of proteinase inhibitor which has a transglutaminase-mediated anchoring sequence termed "cementoin".
    Nara K; Ito S; Ito T; Suzuki Y; Ghoneim MA; Tachibana S; Hirose S
    J Biochem; 1994 Mar; 115(3):441-8. PubMed ID: 7914520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor XIIIa-derived peptides inhibit transglutaminase activity. Localization of substrate recognition sites.
    Achyuthan KE; Slaughter TF; Santiago MA; Enghild JJ; Greenberg CS
    J Biol Chem; 1993 Oct; 268(28):21284-92. PubMed ID: 8104938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-thrombolysis haemostasis changes after rt-PA treatment in acute cerebral infarct. Correlations with cardioembolic aetiology and outcome.
    Sun X; Berthiller J; Derex L; Trouillas P; Diallo L; Hanss M
    J Neurol Sci; 2015 Feb; 349(1-2):77-83. PubMed ID: 25619569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis.
    Weinberg JB; Pippen AM; Greenberg CS
    Arthritis Rheum; 1991 Aug; 34(8):996-1005. PubMed ID: 1677574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.